Drug Insights

How to Effectively Search for Tizanidine on Synapse

2 February 2024
2 min read

Tizanidine Hydrochloride, a minuscule molecule drug, is a potent agonist that targets the ADRA2 receptor with high specificity. This drug is extensively employed in the management of muscle spasticity in patients with multiple sclerosis, paralysis, and myotonia. It was granted the first approval on January 20th, 1988, and was developed by the esteemed pharmaceutical company, Novartis. Tizanidine Hydrochloride acts as an agonist to the ADRA2 receptor within the central nervous system, resulting in a marked decrease in the release of excitatory neurotransmitters, which efficiently reduces muscle spasticity. The drug, however, should be used with caution as it can cause certain side effects, including drowsiness, dizziness, and dry mouth. Additionally, taking Tizanidine Hydrochloride with other medications that can cause sedation is not recommended. To ensure its safe and effective use, Tizanidine Hydrochloride should only be used under the close supervision of a healthcare provider, and patients should be carefully monitored for any adverse effects. Click on the image below to begin the exploration journey of Tizanidine through the Synapse database!

图形用户界面, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Dupixent® Gets FDA Approval for Eosinophilic Esophagitis Treatment in Pediatric Patients
Latest Hotspot
3 min read
Dupixent® Gets FDA Approval for Eosinophilic Esophagitis Treatment in Pediatric Patients
2 February 2024
Dupixent® has been granted FDA approval as the exclusive therapy indicated for pediatric patients over the age of 1 diagnosed with eosinophilic esophagitis (EoE).
Read →
Your Ultimate Guide to Finding Bupropion on Synapse
Drug Insights
2 min read
Your Ultimate Guide to Finding Bupropion on Synapse
2 February 2024
Bupropion Hydrochloride is a tiny molecule drug that targets multiple functions, including dopamine transporter (DAT), adrenergic receptor, and CYP2D6.
Read →
New Phase II Findings for ODM-208/MK-5684 Revealed at 2024 ASCO-GU Conference
Latest Hotspot
3 min read
New Phase II Findings for ODM-208/MK-5684 Revealed at 2024 ASCO-GU Conference
2 February 2024
Orion Presents New Insights from Phase II CYPIDES Trial on ODM-208 at 2024 ASCO Symposium.
Read →
Explore Phentermine on Synapse: Tips and Tricks for Better Search Results
Drug Insights
2 min read
Explore Phentermine on Synapse: Tips and Tricks for Better Search Results
2 February 2024
Phentermine, a small molecular compound, targets the TAAR1 receptor as an agonist and serves as an appetite suppressant for obesity management.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.